🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
Banner University Medical Center ( Site 0356)
Start Date
2019-10-08
Trial ID
NCT03969901
Treatments Being Tested
Extracorporeal membrane oxygenation (ECMO) is a from of cardiopulmonary lif...
Status
Completed
Location
Hartford Hospital
Start Date
2021-01-01
Trial ID
NCT04493151
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-16
Trial ID
NCT01505634
This is a multicenter stepped-wedge cluster randomized trial, conducted ove...
Status
Not Yet Recruiting
Location
Irccs Azienda Ospedaliero-Universitaria Di Bologna
Start Date
2026-10-01
Trial ID
NCT07759453
This study is an open-label, multiple-dose pharmacokinetic study of imipene...
Status
Withdrawn
Location
University of Illinois at Chicago
Start Date
2023-01-01
Trial ID
NCT05146154
Treatments Being Tested
This study aims to obtain plasma pharmacokinetic (PK) data and characterize...
Status
Completed
Location
Arkansas Children's Hospital ( Site 1311)
Start Date
2017-11-06
Trial ID
NCT03230916
Treatments Being Tested
This is a 2-part study of the pharmacokinetics (PK) of MK-7655. In Part I, ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-28
Trial ID
NCT01275170
Treatments Being Tested
This is an observation study comparing prospective use of Imipenem/Cilastat...
Status
Withdrawn
Location
Carolinas Medical Center
Start Date
2021-06-07
Trial ID
NCT04785924
Treatments Being Tested
This phase II trial studies the effect of imipenem-relebactam in treating p...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-09-14
Trial ID
NCT04983901
The global dissemination of carbapenem-resistant Enterobacteriaceae (CRE) a...
Status
Unknown
Location
D'Or Institute for Research and Education (IDOR)
Start Date
2022-04-01
Trial ID
NCT05285046
Treatments Being Tested